| Project Detail |
The project supports the construction, furnishing and validation of the second phase of a commercial scale production facility for vaccines and biological medicines. It also includes technology transfer, research, development and innovation (RDI) activities of a Colombian biotech company targeting areas of high unmet medical need. Objectives The aim is to support innovation and improved access to innovative medicines by leveraging private sector engagement, thereby helping to stimulate growth and decent jobs, facilitate trade, diversify global value chains and reinforce health, scientific and diplomatic ties with partner countries, while advancing universal health coverage, and human development and public health objectives. The operation will boost local manufacturing, create jobs, and enhance access to affordable health products in Colombia and therefore in Latin America. It will reduce health inequities, and strengthen regional health resilience. Improved vaccine distribution will lower disease rates, reduce healthcare costs, and increase productivity, leading to economic growth and better quality of life. Comments Project financed under the European Fund for Sustainable Development Plus (EFSD+) Open Architecture Accelerating Human Development Guarantee. Sector(s) Industry - Manufacturing Under Global Europe NDICI guarantee Under EFSD+ Guarantee Proposed EIB finance (Approximate amount) EUR 45 million Total cost (Approximate amount) EUR 100 million |
